Prescription sales of leading anti-obesity drugs stuck in doldrums

Makers of leading anti-obesity medicines were hardest hit by the season influence in the period ranging from October 2007 to January this year.

Analysts say, however, that the anti-obesity market will pick up steam in the coming months on roust domestic demand.

The domestic anti-obesity market has been contested by a number of competitors – Abbott Korea, Hanmi Pharm, Yuhan Corp., Da...